Paydirt
BV
Insider

Bahram Valamehr

President and CEO

Bahram Valamehr (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Fate Therapeutics, Inc. (FATE). The largest single filing was $108K of FATE (43,947 sh × $2.46, as filed), executed Aug 4.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$108K
shares × price, as filed
Last traded
Aug 4
Filed Aug 5

Median ADV $9.7M across their filed names

Open performance→
Volume by month
$108K$54K$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2026 · sells $108K
Buys $0 Sells $108K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
FATE Fate Therapeutics, Inc. FATE · 0 buys · 1 sell 1 filing
Recent filings
FATESALE Fate Therapeutics, Inc. View filing → $108K
43,947 sh × $2.46
Exec Aug 4
Filed Aug 5 · 4:01 PM ET